Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Cancer Letters|August 24, 2014
miR-21-3p is a positive regulator of L1CAM in several human carcinomasKai Doberstein, Niko P Bretz, Uwe Schirmer, et al.Carcinogenesis|November 25, 2010
L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cellsKai Doberstein, Anja Wieland, Sophia B Boyoung Lee, et al.Immunology Letters|June 24, 2014
Lack of CD24 expression in mice reduces the number of leukocytes in the colonNiko P Bretz, Alexei V Salnikov, Kai Doberstein, et al.Biochemical and Biophysical Research Communications|March 3, 2009
Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinomaPaul Gutwein, Anja Schramme, Beren Voss, et al.Communications Biology|October 1, 2025
Long non-coding RNAs as a biomarker for homologous recombination deficiency and parp inhibitor sensitivity in high-grade serous ovarian cancersKai Doberstein, Johannes Panther, Eric Hahnen, et al.Plos One|August 31, 2011
PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cellsSophia Boyoung Lee, Kai Doberstein, Peter Baumgarten, et al.Journal of Biomedical Science|January 15, 2010
ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseasesPaul Gutwein, Anja Schramme, Mohamed Sadek Abdel-Bakky, et al.The Journal of Investigative Dermatology|October 30, 2009
ADAM10 is upregulated in melanoma metastasis compared with primary melanomaSophia B Lee, Anja Schramme, Kai Doberstein, et al.BMC Cancer|December 17, 2014
L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptorKai Doberstein, Karin Milde-Langosch, Niko P Bretz, et al.Oncotarget|February 6, 2014
Role of miR-34a as a suppressor of L1CAM in endometrial carcinomaUwe Schirmer, Kai Doberstein, Anne-Kathleen Rupp, et al.Pageof 3